Citation tools
"The selexipag active metabolite ACT-333679 displays strong anti-contractile and anti- remodeling effects, but low β-arrestin recruitment and desensitization potential." Journal of Pharmacology and Experimental Therapeutics
(2017):
jpet.116.239665.
Web. 23 April. 2024.